Interleukin-1beta-induced insulin resistance in adipocytes through down-regulation of insulin receptor substrate-1 expression. - Wikidata - awgldk - TriplyDB

Interleukin-1beta-induced insulin resistance in adipocytes through down-regulation of insulin receptor substrate-1 expression.

Interleukin-1beta-induced insulin resistance in adipocytes through down-regulation of insulin receptor substrate-1 expression.

http://www.wikidata.org/entity/Q41862754

about

Rab4b is a small GTPase involved in the control of the glucose transporter GLUT4 localization in adipocyte Sickness-Associated Anorexia: Mother Nature's Idea of Immunonutrition?Influence of Acute and Chronic Exercise on Glucose Uptake Adipose tissue macrophages: going off track during obesity The Macrophage Switch in Obesity Development An Evolutionary Perspective of Nutrition and Inflammation as Mechanisms of Cardiovascular Disease Biological and Nutritional Properties of Palm Oil and Palmitic Acid: Effects on Health Is immunity a mechanism contributing to statin-induced diabetes?Insulin receptor signaling in normal and insulin-resistant states Potential roles of GPR120 and its agonists in the management of diabetes A clear and present danger: inflammasomes DAMPing down disorders of pregnancy Therapeutic roles of heme oxygenase-1 in metabolic diseases: curcumin and resveratrol analogues as possible inducers of heme oxygenase-1 A Potential Role for Pro-Inflammatory Cytokines in the Development of Insulin Resistance in Horses Implication of inflammatory signaling pathways in obesity-induced insulin resistance Regulation of Nlrp3 inflammasome by dietary metabolites Dysregulation of cytokine response in Canadian First Nations communities: is there an association with persistent organic pollutant levels?Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance Cellular and molecular players in adipose tissue inflammation in the development of obesity-induced insulin resistance Role of the immune system in hypertension: modulation by dietary antioxidants.Tpl2 kinase is upregulated in adipose tissue in obesity and may mediate interleukin-1beta and tumor necrosis factor-{alpha} effects on extracellular signal-regulated kinase activation and lipolysis.The metabolic syndrome MyD88-dependent interplay between myeloid and endothelial cells in the initiation and progression of obesity-associated inflammatory diseases.Deficiency of oncostatin M receptor β (OSMRβ) exacerbates high-fat diet-induced obesity and related metabolic disorders in mice.Humoral sleep regulation; interleukin-1 and tumor necrosis factor Abnormal Glucose Metabolism in Rheumatoid Arthritis Mechanisms of inflammatory responses in obese adipose tissue.Cytokines in immune function and sleep regulation.Interactive changes between macrophages and adipocytes.Immune cell-derived cytokines contribute to obesity-related inflammation, fibrogenesis and metabolic deregulation in human adipose tissue.A serum factor induces insulin-independent translocation of GLUT4 to the cell surface which is maintained in insulin resistance.Improved insulin sensitivity in high fat- and high cholesterol-fed Ldlr-/- mice with macrophage-specific transgenic expression of cholesteryl ester hydrolase: role of macrophage inflammation and infiltration into adipose tissue.Insulin upregulates betatrophin expression via PI3K/Akt pathway Ras inhibition induces insulin sensitivity and glucose uptake.Interleukin-1β mediates macrophage-induced impairment of insulin signaling in human primary adipocytes.NCoR repression of LXRs restricts macrophage biosynthesis of insulin-sensitizing omega 3 fatty acids.Leukocyte infiltration and activation of the NLRP3 inflammasome in white adipose tissue following thermal injury Macadamia oil supplementation attenuates inflammation and adipocyte hypertrophy in obese mice Interleukin-1 beta: a potential link between stress and the development of visceral obesity.Adipose tissue promotes a serum cytokine profile related to lower insulin sensitivity after chronic central leptin infusion

P2860

Q24312899-33FE2211-00BF-4DDC-9256-40DADD0DC9CE Q26738529-AF9E4E48-99FD-45D5-A5F1-E89ABF6CD58E Q26748964-AE76CE6E-988B-49B3-B33D-83583C9F3092 Q26768692-2473C4B1-AB87-49D3-987F-930A8F921932 Q26771455-D6D6E5A6-C458-4C80-8781-F4A7737C5A42 Q26773580-6D2D2920-A897-4B34-B827-F2DC02DB4778 Q26782354-17B69D9A-69A9-4F6E-93FE-DEB93CCCF5B8 Q26785561-7D86FCAF-5793-4139-9486-DF05C5726371 Q26823171-FA92A477-D552-43BB-A051-4C531E94C8DB Q26827101-DCC2BC6D-0FBA-4882-AB34-9F3A5BB9C330 Q27007734-56FA0D04-A7C5-43CD-8733-5AC7F7A28D28 Q27021350-DACC450C-4242-48A8-A506-60CB59ACFD8A Q27026242-5C6421FC-EC3C-4BDE-B2B3-BC4151860AE3 Q27500365-A74A28F8-ABA1-40A0-B587-D3626F0B3495 Q28078340-21723703-617E-4A4D-8F29-6909FB584D73 Q28385984-256AD19A-69A9-41BF-8D8D-DE3FC5D2D409 Q29616024-AF635221-F2B8-46D4-9FAC-983076AAC66E Q29616026-699831AD-FD2E-4ECE-8EB9-D35ED2506BDB Q30009848-0A2CE260-1ABA-44B9-94CD-A3C4FDCEE2CC Q30424339-FD3FAB8E-9FFF-484B-BA36-015F0AD628D9 Q33556670-FE4BF8B0-512E-4B8C-9841-2EDB32998DEE Q33569142-AE8E338E-7DEE-4345-9B27-AFB51AA1F68F Q33569870-839A8172-40B8-4433-B95B-43D8BA299F9E Q33619351-7700D8C5-4290-4C6A-8DC1-F9858198548F Q33648273-C1283725-C1D7-4E6C-848D-14B4975698CB Q33654451-9E369261-DBA8-4204-85E1-900D8B8A5102 Q33699810-BB88781B-B4FB-4DEE-B106-78E943387FAE Q33716410-A9929266-74CF-4939-B0F1-53C31E34ED6B Q33768617-66E426D4-FF40-49F6-A93C-712EA9C693AA Q33774339-C08E32D5-13AB-4517-B70A-BCDBCA33DBDE Q33781146-F37D4BA3-F3C4-4472-B14A-BE34C433F009 Q33810018-A0E6F92C-11B9-4738-856F-5A1DD9AC29EE Q33912235-57F97085-5DD5-4593-AFDA-D1BBEF257D99 Q33955305-56C79A02-6C18-4129-828E-2E68CAB86CBF Q34001345-083F1771-9CF6-4B92-B17F-23FED2C3D831 Q34040157-63586119-B4EE-4DEA-A790-389DDCBCB058 Q34200054-205E3B8B-07EA-4750-8824-72F927E49F8C Q34308198-16050D2C-BA84-4DF2-9D46-4E2B8E36900F Q34318738-6F5E59EE-3FC4-421C-A01B-D5FBEB9E1386 Q34442433-43E1A5F0-63B9-4DB6-9E30-94F265341B35

P2860

Interleukin-1beta-induced insulin resistance in adipocytes through down-regulation of insulin receptor substrate-1 expression.

http://www.wikidata.org/entity/Q41862754

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

Interleukin-1beta-induced insu ...... ceptor substrate-1 expression.

@en

type

label

Interleukin-1beta-induced insu ...... ceptor substrate-1 expression.

@en

prefLabel

Interleukin-1beta-induced insu ...... ceptor substrate-1 expression.

@en

P1433

Q41862754-0D31FDB4-A9C2-46D0-B9C6-59C0F4C712DF

P1476

Q41862754-6AF44088-B252-400A-9C16-D5D83AB2256A

P2093

Q41862754-0A898A8B-CA98-42BC-AA80-605EB3CD920D

Q41862754-C28EDC9B-746B-4064-815D-EA521CE21B34

P2860

Q41862754-0A66A7A4-8FDB-4475-85F0-279B3BB5217E

Q41862754-1875A655-5DDB-4055-A5BC-E25215EB0E11

Q41862754-1BE928FD-559B-416E-A82E-6C8CDFDB59F3

Q41862754-28159AAD-0EEF-4338-AAC5-8DDE08B7ECD0

Q41862754-28A53A6C-C0D1-431A-8523-FEF2C47F91D1

Q41862754-3245A676-9510-4000-B48A-665BA6A92B27

Q41862754-357FBE0E-1351-4915-BEE4-92C86F9BBB37

Q41862754-38FAD76D-1F5A-4FFF-85C7-D4E355734143

Q41862754-3FA6B733-8C8E-45A1-B647-21566DA464FF

Q41862754-457ADEE4-E076-483F-B0D6-03CB7075A4CC

P304

Q41862754-CDDDC2D1-2EDF-474A-8DAD-D34EC7B75F2F

P31

Q41862754-DF88F88B-79CC-49F7-9E4B-35A4844C5C25

P356

Q41862754-4DF74868-EB21-412A-A92C-C13C4E85F60D

P407

Q41862754-04C5D2B1-1D2A-4BCD-9D99-9F11CD5A4632

P433

Q41862754-007FC744-B424-4E7C-81DE-3315C7A51A8D

P478

Q41862754-D50CF404-01FA-43CB-A175-0F9738A2698D

P50

Q41862754-74456988-8301-4F5B-A254-4681A7818F59

Q41862754-C60A18E4-2F10-40A9-AB0F-FB611F22A713

Q41862754-F437A56A-DABD-4051-8E29-43F0C21018C7

P577

Q41862754-0BD85DE4-06DE-490A-AF94-66738FDCFE45

P5875

Q41862754-530D11FD-0A82-4674-ABAD-7FC21B7D63C5

P698

Q41862754-B3E2E2D0-BE36-414E-B45E-CF5D220F26CD

P921

Q41862754-8A90547C-CE08-4B76-8EE6-C143C1ECDF7A

P932

Q41862754-A0C14C9C-C8CD-4BCC-9464-C007D2FFAAAA

P356

P1433

P1476

Interleukin-1beta-induced insu ...... ceptor substrate-1 expression.

@en

P2093

Thierry Grémeaux

http://www.w3.org/2001/XMLSchema#string

Yannick Le Marchand-Brustel

http://www.w3.org/2001/XMLSchema#string

P2860

Long-term treatment with interleukin-1beta induces insulin resistance in murine and human adipocytes

Inflammation, stress, and diabetes

Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance

Obesity is associated with macrophage accumulation in adipose tissue

The c-Jun NH(2)-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser(307)

SOCS-1 and SOCS-3 block insulin signaling by ubiquitin-mediated degradation of IRS1 and IRS2

Hyperosmotic stress inhibits insulin receptor substrate-1 function by distinct mechanisms in 3T3-L1 adipocytes

Positive and negative regulation of insulin signaling through IRS-1 phosphorylation

MAP kinases and mTOR mediate insulin-induced phosphorylation of insulin receptor substrate-1 on serine residues 307, 612 and 632

Suppressor of cytokine signaling 1 (SOCS-1) and SOCS-3 cause insulin resistance through inhibition of tyrosine phosphorylation of insulin receptor substrate proteins by discrete mechanisms

P304

241-251

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1210/EN.2006-0692

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

148

http://www.w3.org/2001/XMLSchema#string

P50

Mireille Cormont

Jean-François Tanti

P577

2006-10-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6756094

http://www.w3.org/2001/XMLSchema#string

P698

17038556

http://www.w3.org/2001/XMLSchema#string

P921

P932

1971114

http://www.w3.org/2001/XMLSchema#string